Trade now with Barclays Stockbrokers
By Abigail Townsend
Date: Thursday 26 Mar 2026
(Sharecast News) - Oxford Biomedica posted a surge in annual revenues on Thursday, but warned it was on track to swing to an interim loss this year before returning to growth in the second half.
| Result of AGM | 07-May-2026 | 16:58 | RNS |
| Total Voting Rights | 01-May-2026 | 07:00 | RNS |
| Admission to Trading | 30-Apr-2026 | 08:15 | RNS |
| Admission to Trading Application | 27-Apr-2026 | 09:51 | RNS |
| Grant of Awards | 08-Apr-2026 | 17:18 | RNS |
| Need to know: Opec cuts forecast ... Tesco cuts ... | 16-Aug-2008 | Times |
| Need to know | 10-May-2008 | Times |
| DSG International may be losing its spark | 12-Feb-2008 | Telegraph |
| Oxford BioMedica clinches $690m licensing deal f... | 29-Mar-2007 | The Independent |
| Oxford Biomedica seals €518m deal with Sanofi ov... | 29-Mar-2007 | Times |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 627.00p |
| Change Today | -22.00p |
| % Change | -3.39 % |
| 52 Week High | 913.00 |
| 52 Week Low | 290.00 |
| Volume | 116,733 |
| Shares Issued | 120.92m |
| Market Cap | £758.17m |
| Beta | 0.03 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 2 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 10 |

| No dividends found |
| Time | Volume / Share Price |
| 13:19 | 100 @ 627.00p |
| 13:13 | 100 @ 627.50p |
| 13:04 | 237 @ 628.00p |
| 13:01 | 1,591 @ 628.33p |
| 12:58 | 2 @ 629.00p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research